Author： D'Haese Jan G Demir Ihsan Ekin Friess Helmut Ceyhan Güralp O
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.2, 2010-02, pp. : 207-219
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. :
Access to resources
Recommend
The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-01 ,pp. :
CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. :
By Boddeke E.W.G.M. Meigel I. Frentzel S. Biber K. Renn L.Q. Gebicke-Harter P.
European Journal of Pharmacology, Vol. 374, Iss. 2, 1999-06 ,pp. :
CX3CR1 as a target for airways inflammation
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. :